Eto M, Nishimura Y, Matsuo K, Omoto K, Goto K, Kumuzawa J, Nomoto K
Department of Urology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Urol. 1995 May;153(5):1693-6.
In this study, we have extended a cyclophosphamide (CP)-induced tolerance system to kidney transplantation in rats to examine whether or not we can overcome fully allogeneic (major histocompatibility complex plus minor histocompatibility) antigen barriers in organ transplantation. In the recipient Lewis (LEW, RT1(1)) rats that were primed intravenously with 4 x 10(8) spleen cells plus 2 x 10(8) bone marrow cells from Brown-Norway (BN, RT1n) rats and treated intraperitoneally with 100 mg./kg. of cyclophosphamide (CP) 2 days later, the survival of kidney allografts, but not skin allografts, from BN was prolonged as compared with that in the untreated LEW rats. Some of the kidney allografts survived for more than 100 days without further immunosuppressants. The tolerant state induced was tolerogen specific, and the suppression of tissue damage of the grafted kidney in such tolerant rats was also confirmed by the histopathological findings of the grafted kidney. These results indicate that considerable levels of tolerance can be induced, at least in organ transplantation, across fully allogeneic antigen barriers in rats by a CP-induced tolerance system. We believe that the present study is the first step in applying our CP-induced tolerance system using skin grafting in the murine model to clinical organ transplantation.
在本研究中,我们将环磷酰胺(CP)诱导的耐受系统扩展至大鼠肾移植,以检验我们是否能够在器官移植中完全克服同种异体(主要组织相容性复合体加次要组织相容性)抗原屏障。在接受静脉注射来自棕色挪威(BN,RT1n)大鼠的4×10⁸个脾细胞加2×10⁸个骨髓细胞并用100mg/kg环磷酰胺(CP)腹腔注射处理的受体刘易斯(LEW,RT1¹)大鼠中,与未处理的LEW大鼠相比,来自BN的肾移植存活时间延长,但皮肤移植存活时间未延长。一些肾移植在没有进一步免疫抑制剂的情况下存活超过100天。诱导的耐受状态具有耐受原特异性,并且通过移植肾的组织病理学结果也证实了此类耐受大鼠中移植肾组织损伤的抑制。这些结果表明,通过CP诱导的耐受系统,至少在器官移植中,可以在大鼠中诱导出相当程度的跨越完全同种异体抗原屏障的耐受性。我们相信,本研究是将我们在小鼠模型中使用皮肤移植的CP诱导耐受系统应用于临床器官移植的第一步。